HANNAH BAKER: Open Payments
NPI 1891446902 · ALBERTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 17 payments from 9 companies in 2025. Trend: 2023 $234 · 2024 $38 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $108 |
| ABBVIE INC. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Amgen Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, UBRELVY, REXULTI, Kerendia, REPATHA, BREZTRI, FARXIGA.
Industry payments across AL — which companies pay providers there.
